Apr 4 2012
The New York Times: White House And The FDA Often At Odds
The internal clashes over F.D.A. policy played out against a broader backdrop of regulatory politics. Republicans have made the charge that Mr. Obama is an overzealous and job-killing regulator -; a central element of their case against his re-election. And on issues from clean air to investor protections, the White House has been carefully calibrating its election season positions (Harris, 4/2).
 This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|